Kihealth’s diabetes assay, which measures the earliest biomarker of insulin resistance, is claimed to be the first diagnostic of its kind.

Company Seeks to Establish a First in the Field of Medicine with Pioneering Diagnostic Algorithm Test Using High Resolution Mass SpectrometryST. LOUIS--(BUSINESS WIRE)--#Alzheimers--C2N Diagnostics, a ...

The flu causes millions of illnesses, hundreds of thousands of hospitalizations and tens of thousands of deaths each year in ...

The numbers show that positive results for both fentanyl and marijuana have doubled since 2020. Tests with both fentanyl and ...

There are no specific diagnostic tools to confirm whether a person suffers from chronic fatigue syndrome. However, doctors can run a battery of tests to strike out the possibility of some other ...

Avak Kahvejian, PhD, a general partner with biotech incubator Flagship Pioneering, discusses how AI is rearchitecting methods ...

OGT, a leading global provider of genomic diagnostic and research solutions, announced today that the U.S. Food and Drug Administration (FDA) has granted their De Novo Classification Request for the ...

The researchers also found that the TriVerity severity score, which predicts the need for ICU-level care, such as mechanical ...

From cancer biology to proactive health management, customized care is changing patient outcomes, but what are the costs and ...

Hologic’s FDA clearance for its Panther Fusion GI Bacterial and Expanded Bacterial Assays represents the company’s entry into the gastroenteritis test market.

Britain's COVID-19 testing system faced more disruption on Wednesday after logistical problems at a Roche warehouse delayed the dispatch of some of the Swiss pharmaceutical giant's products.

Through the collaboration with Genomind, Adial can now test SNPs in the HTR3A, HTR3B, and SLC6A4 gene. Additionally, Adial can test long and short forms of the SLC6A4 promoter. Genomind validated the ...